Skip to main content

Vetera GoldXP

This page contains information on Vetera GoldXP for veterinary use.
The information provided typically includes the following:
  • Vetera GoldXP Indications
  • Warnings and cautions for Vetera GoldXP
  • Direction and dosage information for Vetera GoldXP

Vetera GoldXP

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

Vetera GoldXP Indications

This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against eastern and western encephalomyelitis (EEE & WEE), west nile virus (WNV), and tetanus, and against respiratory disease due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4) and A2 equine influenza virus (EIV). The duration of immunity against EIV OH/03 is at least 6 months and against WNV is at least 12 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

This product has also been shown to be effective against shedding due to A2 EIV and against viremia, mortality, and neurologic clinical disease due to WNV.

Composition

Contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) EIV strains. Amphotericin B and gentamicin added as preservatives.

Directions and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.

Precautions

Store at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

For use in animals only

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

© 2019 Boehringer Ingelheim Animal Health USA Inc. All rights reserved.

US Patent Nos. 7572620, 8535685, 8697089, 8784838, 6803041, 7226604, and 8821889.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/4855.A0

1 Dose/1 mL

137110-01

10 Doses/10 mL

137109-01

CPN: 1028268.3

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., DULUTH, GA, 30096
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bi-vetmedica.com
    www.metacam.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
Email:   info@productionvalues.us
This service and data are provided "AS IS". DVMetrics and Drugs.com assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and Drugs.com services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-12-02